Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.09M | Sell |
16,755
-2,888
| -15% | -$628K | ﹤0.01% | 1574 |
|
|
2026
Q2 | $4.81M | Buy |
+19,643
| New | +$4.26M | ﹤0.01% | 1239 |
|
|
2026
Q1 | – | Sell |
-25,222
| Closed | -$4.36M | – | 9041 |
|
|
2025
Q4 | $4.61M | Buy |
25,222
+12,646
| +101% | +$1.77M | ﹤0.01% | 1336 |
|
|
2025
Q3 | $1.53M | Sell |
12,576
-743
| -6% | -$83.7K | ﹤0.01% | 2594 |
|
|
2025
Q2 | $1.39M | Buy |
+13,319
| New | +$1.41M | ﹤0.01% | 2447 |
|
|
2025
Q1 | – | Sell |
-2,942
| Closed | -$335K | – | 8505 |
|
|
2024
Q4 | $248K | Sell |
2,942
-12,714
| -81% | -$1.17M | ﹤0.01% | 4280 |
|
|
2024
Q3 | $1.41M | Buy |
15,656
+7,036
| +82% | +$614K | ﹤0.01% | 2589 |
|
|
2024
Q2 | $693K | Sell |
8,620
-6,766
| -44% | -$501K | ﹤0.01% | 3303 |
|
|
2024
Q1 | $1.23M | Sell |
15,386
-5,427
| -26% | -$456K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $1.66M | Buy |
20,813
+13,267
| +176% | +$887K | ﹤0.01% | 2523 |
|
|
2023
Q3 | $527K | Sell |
7,546
-6,795
| -47% | -$508K | ﹤0.01% | 3343 |
|
|
2023
Q2 | $1.03M | Buy |
14,341
+13,781
| +2,461% | +$1.02M | ﹤0.01% | 2568 |
|
|
2023
Q1 | $34K | Sell |
560
-15,802
| -97% | -$1.04M | ﹤0.01% | 6355 |
|
|
2022
Q4 | $1.26M | Sell |
16,362
-21,689
| -57% | -$1.3M | ﹤0.01% | 2253 |
|
|
2022
Q3 | $1.7M | Buy |
38,051
+11,711
| +44% | +$585K | ﹤0.01% | 2103 |
|
|
2022
Q2 | $1.01M | Buy |
26,340
+25,340
| +2,534% | +$801K | ﹤0.01% | 2613 |
|
|
2022
Q1 | $41K | Sell |
1,000
-19,927
| -95% | -$618K | ﹤0.01% | 7403 |
|
|
2021
Q4 | $790K | Buy |
20,927
+10,592
| +102% | +$390K | ﹤0.01% | 3191 |
|
|
2021
Q3 | $705K | Sell |
10,335
-200
| -2% | -$7.79K | ﹤0.01% | 3591 |
|
|
2021
Q2 | $710K | Buy |
10,535
+10,198
| +3,026% | +$612K | ﹤0.01% | 3627 |
|
|
2021
Q1 | $19K | Sell |
337
-6,285
| -95% | -$442K | ﹤0.01% | 7483 |
|
|
2020
Q4 | $0 | Sell |
6,622
-4,245
| -39% | -$317K | ﹤0.01% | 8310 |
|
|
2020
Q3 | $0 | Sell |
10,867
-2,012
| -16% | -$157K | ﹤0.01% | 7767 |
|
|
2020
Q2 | $0 | Sell |
12,879
-10,943
| -46% | -$842K | ﹤0.01% | 7584 |
|
|
2020
Q1 | $1.4M | Buy |
23,822
+21,109
| +778% | +$1.72M | ﹤0.01% | 1575 |
|
|
2019
Q4 | $280K | Sell |
2,713
-24,371
| -90% | -$984K | ﹤0.01% | 3370 |
|
|
2019
Q3 | $548K | Buy |
+27,084
| New | +$696K | ﹤0.01% | 2528 |
|
|
2019
Q2 | – | Sell |
-13,097
| Closed | -$263K | – | 7067 |
|
|
2019
Q1 | $186K | Buy |
13,097
+12,697
| +3,174% | +$118K | ﹤0.01% | 3697 |
|
|
2018
Q4 | $1K | Buy |
400
+300
| +300% | +$987 | ﹤0.01% | 6703 |
|
|
2018
Q3 | $0 | Buy |
+100
| New | +$296 | ﹤0.01% | 7385 |
|
Other funds holding AXSM
Simplex Trading's AXSM Position: Q3 2026 in Review
Simplex Trading reduced its Axsome Therapeutics (AXSM) stake by 15% in Q3 2026, selling an estimated $628K and leaving 16,755 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.
Simplex Trading first reported a position in AXSM in Q3 2018 and has held it in 30 quarters since. The position peaked at $4.81M in Q2 2026. 235 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Simplex Trading held 16,755 shares of Axsome Therapeutics worth $3.09M as of Q3 2026.
- Simplex Trading sold 2,888 Axsome Therapeutics shares in Q3 2026, an estimated $628K.
- Axsome Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #1574 holding.
- Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and has held it in 30 quarters since.
- Simplex Trading's Axsome Therapeutics position peaked at $4.81M in Q2 2026.
- 235 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.